Recall of Brexafemme® Due to Dangerous Contamination - MedWaste Management Recall of Brexafemme® Due to Dangerous Contamination - MedWaste Management

Medical Waste and the Healthcare Industry Blog

Stay tuned to our blog for timely updates and insights into the ever-evolving landscape of medical waste news and developments.

Recall Brexafemme

Recall of Brexafemme® Due to Dangerous Contamination

An urgent recall of a one-time-dose treatment for vaginal yeast infection has been issued after the discovery of a dangerous contaminant in the drug. Brexafemme® (ibrexafungerp) tablets are manufactured by Scynexis, Inc. During a routine inspection, the presence of a non-antibacterial β-lactam drug substance was noted. When ingested, the substance can cause severe reactions, including death. As of the writing of this notice, no adverse events have yet been reported.

SUMMARY

Date of Recall:

Announced: September 27, 2023

Public Notification: September 28, 2023

Name(s) of Drug:

Brexafemme (ibrexafungerp)

Company Name:

Scynexis, Inc.

Drug Indication:

Fungal Infection

Vaginal Yeast Infection

Vulvovaginal Candidiasis

Recurrent Vulvovaginal Candidiasis

Recall Brexafemme Packaging

Recall Brexafemme Packaging

Product Description

The prescription medication is distributed by pharmacies nationwide. The pills are oval-shaped and purple. Each bears the number 150 on one side and the letters SCY on the other. The pills are distributed in blister packs that are contained within a box containing blue, yellow, green, and pink accents.

Reason for Recall

Scynexis, Inc. noted contamination with a non-antibacterial β-lactam during the manufacturing process. They are issuing the recall out of an abundance of caution, though no adverse events have yet been reported.

Impacts

Consumers who receive and consume a contaminated batch of the medication may experience:

  • Edema (swelling)
  • Dermatitis (rash)
  • Urticaria (hives)
  • Anaphylaxis (allergic reaction leading to inability to breathe, vomiting, nausea, weak/rapid pulse, low blood pressure)

Lot Information

Consumers should locate the box in which the medication comes to compare NDC, lot numbers, and expiration dates with the chart below. If you find your NDC number, lot number, and expiration date on the chart below, your medication is affected by the recall, and you will need to take additional steps to ensure that your health is not affected and to take part in recall procedures.

Product Description
NDC
Lot Number
Expiration Date
BREXAFEMME®

75788-115-04

LF21000008

11/2023

BREXAFEMME®

75788-115-04

LF22000051

11/2025

FDA.gov

Have you found that your medication is part of the recall? Here’s what you should do:

Consumers

  1. Call your doctor right away. Ask for a new prescription to replace your recalled medication and report any changes in your symptoms.
  2. Continue to monitor your health for any adverse symptoms. Notify your physician if any concerns are noted.
  3. Consumers may contact Sedgwick at 1-877-551-7154. They are available Mon-Fri from 8:00 a.m. to 5:00 p.m. (EST). You can also contact them via email at media@scynexis.com.
  4. If you are currently experiencing or have experienced an adverse reaction to this medication (listed above), notify your physician immediately and notify the FDA by calling 1-800-332-1088 or completing an online reporting form.
  5. Contact MedWaste Management for information and assistance with disposing of the recalled medication.

Retailer

  1. Examine all inventory and remove stock affected by the recall immediately.
  2. Contact Sedgwick at 1-877-551-7154, or you can utilize media@scynexis.com to contact them via email. Notify them of any recalled batches that have already been sold to consumers.
  3. Notify affected consumers of recalled batches that they have already or will receive.
  4. Contact MedWaste Management for information and assistance with disposing of the recalled medication.

Wholesaler

  1. Examine all inventory and remove stock affected by the recall immediately.
  2. Contact Sedgwick at 1-877-551-7154, or you can utilize media@scynexis.com to contact them via email. Notify them of any recalled batches that have already been shipped to retailers.
  3. Notify affected retailers of recalled batches that they have already or will receive.
  4. Contact MedWaste Management for information and assistance with disposing of the recalled medication.

 

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management fills a need for compliant and safe medical waste disposal to the healthcare industry and the general public alike. We publish this blog to spread useful and practical information to help you stay safe, smart, and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to help!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store

Learn How To Properly Manage & Dispose of Household Medical Waste

 

Tammy McKinney, Nurse Writer

 

Tammy McKinney, RN, creator of HelpfulHospiceNurse, is a healthcare writer and seasoned registered nurse. With experience in acute care, long-term care, rehabilitation, drug & alcohol, and hospice & palliative care, she combines her medical understanding with her love for writing to educate and inform the public on various health-related topics. You can view a snippet of her portfolio here or reach out to her directly on LinkedIn!

 

I know I can count on you all to collect everything and do it safely.

You are a great company to work with. At our pharmaceutical production laboratory. We have gallons of leftover pharmaceutical waste that are a headache for our techs to deal with. I know I can count on you all to collect everything and do it safely. I’m pleased with the personal service.

M

Mitchell Adam

Got questions? Need our services?

We’ll get back to you by tomorrow — latest!

Fill the form